Here's an overview of all the newsarticles that have been published on the RX alliance. website.
You can also search for an article in the archives using the form below.
You can also search for an article in the archives using the form below.
This page shows you the 15 latest published newsitems.
| Wednesday 07 July 2010 | Pierre Fabre will market Bilastine in France and Belgium Pierre Fabre will market Bilastine in France and Belgium Pierre Fabre Medicâment, the French leading pharmaceutical company, will market in France and Belgium the antihistamine bilastine, researched and developed by the Spanish company Faes Farma. Bilastine is considered a part of new... |
 |
|
| Tuesday 22 June 2010 | Faes Farma and SLA Pharma sign agreement on Metronidazole Faes Farma and SLA Pharma sign agreement on Metronidazole Faes Farma signs exclusive marketing agreement to manufacture and distribute Topical Metronidazole in Spain, Portugal and Latin America. Faes Farma and SLA Pharma AG, a Swiss based company specialised in the development of prod... |
|
|
| Tuesday 05 January 2010 | Faes Farma licences Bilastine´s marketing rights to Nycomed Faes Farma licences Bilastine´s marketing rights to Nycomed Faes Farma and the European multinational Nycomed have signed a licence agreement for the commercialization of Bilastine in Brazil. With this agreement, Bilastine will be commercialized in the Brazilian market by one of the t... |
|
|
| Friday 11 December 2009 | Faes Farma and MSD sign commercial agreement on etoricoxib Faes Farma, S.A. signs an agreement with Merck Sharp & Dohme Spain, S.A. for the commercialization of the anti-inflammatory etoricoxib. Faes Farma has subscribed an agreement with MSD Spain, subsidiary of the North American multinational Merck & Co Inc., which occupies the second place... |
|
|
| Wednesday 25 November 2009 | Faes Farma and Laboratorios Cinfa sign agreement Faes Farma and Laboratorios Cinfa sing an agreement in order to promote the commercialization of generis products in Portugal. Faes Farma and Laboratorios Cinfa have signed today an agreement for the commercialization and distribution of generic products in Portugal. By means of this strategi... |
|
|
| Friday 13 November 2009 | FAES FARMA signs licensing agreement with PFIZER in Mexico FAES FARMA signs licensing agreement with PFIZER to market Bilastine in Mexico. Faes Farma has entered into a licensing agreement with Pfizer, the world’s leading biopharmaceutical company. Under the terms of the agreement, Pfizer obtains the rights to commercialize Bilastine in Mexico. Fae... |
|
|
| Wednesday 30 September 2009 | Preliminary evaluation report on Bilastine COMMUNICATION Within the scheduled period, the German Medicines Agency, as reference member state for the registration process of Bilastine, has sent today to FAES FARMA, S.A. and to the Agencies of the other 28 affected member states, the preliminary evaluation report on Bilastine’s registr... |
|
|
| Tuesday 24 March 2009 | Faes Farma licenses Bilastine to Merck Serono in India Faes Farma licencia a Merck-Serono la Bilastina en India Faes Farma firma con Merck-Serono el contrato de cesión de los derechos de comercialización de Bilastina en India, tras la formalización de la Carta de Intenciones el pasado octubre. La multinacional Merck-Serono ... |
|
|
| Thursday 19 March 2009 | Ewopharma signs Agreement with BioGaia for Croatia & Serbia Ewopharma signs Agreement with BioGaia for Croatia & Serbia Ewopharma AG has extended its collaboration with the Swedish company BioGaia by signing an Agreement for the exclusive distribution of BioGaia’s probiotic tablets and drops in Croatia and Serbia. “We are very pleased ... |
|
|
| Monday 02 March 2009 | Tramedico Logistics Services signs agreement with B-Medical March 01, 2009 - Weesp – Tramedico Logistic Services BV announced today the signature of a Service Level Agreement for the logistic service with the Dutch pharmaceutical company B-Medical B.V., located in Naarden, NL. Mr. M.C. Beunk, GM of Tramedico Logistic Services B.V. mentioned that he is... |
|
